A consistent message within critical care publications has been that a restrictive transfusion strategy is non-inferior, and possibly superior, to a liberal strategy for stable, non-bleeding critically ill patients. Translation into clinical practice has, however, been slow. Here, we describe the degree of adherence to UK best practice guidelines in a regional network of nine intensive care units within Wessex. All transfusions given during a 2-month period were included (n = 444). Those given for active bleeding or within 24 h of major surgery, trauma or gastrointestinal bleeding were excluded (n = 148). The median (IQR [range]) haemoglobin concentration before transfusion was 73 (68-77 [53-106]
Introduction
Translational science is the process of turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public. It is a field of investigation focused on understanding the scientific and operational principles that underlie each step of the translational process [1] . It has often been stated that it takes up to 17 years for this to occur [2] , the so-called 'secondary translational gap' [3] . Few studies in the last 20 years have caused a sea-change in the practice of critical care, but arguably the 1999 paper by H ebert et al. did exactly this. Before the publication of the TRICC study it was commonplace to aim for a haemoglobin concentration of > 100 g.l À1 in all critically ill patients [4] . This persistent and at times dogmatic approach by some intensivists took many years to change. The ABC and CRIT cohort studies undertaken after the publication of the TRICC study are testament to this, both revealing that practice had changed very little since publication of the TRICC trial [5, 6] . In the intervening years, many other landmark papers emerged, some of which filled gaps from exclusion criteria in the original TRICC study (Table 1 ). The consistent message has been that a restrictive transfusion strategy is non-inferior, and is in some cases superior to a liberal strategy for critical care patients. Evidence for how to manage patients with acute coronary syndrome remains weak, but many believe that a higher threshold may be beneficial, and certainly practice within the UK has commonly aimed for 90-100 g.l À1 in this group. The TITRe2 study was set up to attempt to answer the question in the elective cardiac surgical population (where UK transfusion practise varied markedly from region to region) [7] . It concluded that there was no difference in the incidence of the primary outcomes, which were: sepsis; an ischaemic event; myocardial infarction; acute kidney injury; or infarction of the gut within 3 months of randomisation. However, a specified post-hoc analysis did show a worrying increase in mortality at 3 months in the restrictive arm [8] . Recent AAGBI guidance has recommended a threshold of 80 g.l À1 for this group, which in an area of uncertainty appears to represent a reasonable compromise [9] , both from a health-economic and patient blood management perspective.
The UK guidelines and the most recent Surviving Sepsis guidelines both suggest a threshold of 70 g.l À1 [4, [10] [11] [12] (Table 2) . However, the Surviving Sepsis guidelines have a clause that effectively allows clinicians to exclude almost all critically ill patients. The accompanying editorial to the TRISS trial eloquently highlighted this, and called for them to be updated in light of the results of the TRISS study [4] .
The aim of this audit was to examine how closely a regional network of intensive care units adhered to UK best practice guidelines, namely that critical care patients who are not actively bleeding should only receive red blood cells when haemoglobin concentration falls below 70 g.l À1 [11] .
Methods
This Liberal: < 10 g.dl
À1
Restrictive: < 8 g.dl
A liberal transfusion strategy did not reduce rates of death, or inability to walk independently on 60-day follow-up, or reduce in-hospital morbidity in elderly patients at high cardiovascular risk Villanuvea et al. (Upper gastrointestinal bleeding 2013) [19] Liberal: < 9 g.dl
Restrictive: < 7 g.dl
As compared with a liberal transfusion strategy, a restrictive strategy significantly improved outcomes in patients with acute upper gastrointestinal bleeding TRISS study (patients with septic shock 2014) [20] Liberal: < 9 g.dl
Among patients with septic shock, mortality at 90 days, rates of ischaemic events and use of life support were similar among those assigned to blood transfusion at a higher haemoglobin threshold and those assigned to blood transfusion at a lower threshold; the latter group received fewer transfusions 18 years of age in participating critical care units were included. Transfusions were excluded if the patient was actively bleeding, or if they occurred within 24 h of surgery, major trauma or upper gastrointestinal bleeding. If there was any doubt regarding the possibility of bleeding, the transfusion episode was removed from the dataset. A subgroup analysis was performed to exclude 'cardiac patients', who were defined as having a primary cardiac diagnosis prompting admission, at least two significant cardiac comorbidities, or evidence that the clinical team considered the patient's main clinical problem to be cardiac-related. Transfusion requests from critical care were collected by transfusion laboratories and cross-referenced with electronic and medical records. Clinical indications for transfusion were obtained from a review of the clinical notes and written information on the transfusion request form. Pre-transfusion laboratorymeasured haemoglobin concentration was obtained from electronic blood test software, and defined as the most recent result published before the start of transfusion. Pre-transfusion haemoglobin concentration measured from arterial blood gas was obtained from daily observation charts and defined in a similar manner. Either the laboratory haemoglobin concentration or the arterial blood gas haemoglobin concentration may have prompted transfusion, and the lowest value was always selected for analysis.
Data were stored securely in a spreadsheet by the local leads, and anonymised before transfer to the centre for analysis. Data were checked and analysed by an individual external to the data collection team. The first two authors independently analysed the data using Excel Office 2010 (Microsoft, Redmond, WA, USA) and then Prism Mac V6 (GraphPad Software, La Jolla, CA, USA). The D'Agostino & Pearson Omnibus normality test and the Shapiro-Wilk normality test were used to check distribution of parameters in the data set.
We planned to collect data on the transfusion trigger that was used. If transfusions were started 08:00-20:00 it was defined as 'normal working day', and any transfusions that were started outside of these times were defined as 'out of hours'. We recorded the number of units of blood that were given during each transfusion episode.
Results
We recruited 159 patients from nine critical care units within eight hospitals in the South of England. Four hundred and forty-four transfusion episodes were captured in the study, of which 296 were eligible for inclusion. Two hundred and fifty-four transfusions were included in the non-cardiac subgroup. Details of exclusions are listed in Fig. 1 
À1
. A transfusion trigger of Hb < 70 g.l À1 on either laboratory or arterial blood gas sample was used for 34% of transfusions, but this figure varied from 9% to 100% between centres ( Fig. 2 and Table 3 ). Thirty-eight percent of transfusion episodes occurred 'out of hours', and this figure varied from 0% to 59% between centres (Table 3) . Twenty-three percent of transfusions were consisted of more than one unit of blood, and occurred without any evidence of repeat measurement of haemoglobin concentration by either laboratory or arterial blood gas measurement. This figure varied from 0% to 49% between centres (Table 3) .
Excluding cardiac patients, haemoglobin concentration before transfusion was 72 (68-77 [50-98]) g.l
, with 36% of transfusion episodes associated with an appropriate transfusion threshold of < 70 g.l À1 on either a laboratory or an arterial blood gas sample (Table 4 ).
Discussion
The majority of blood transfusions given to stable critically ill patients in this study used a haemoglobin threshold > 70 g.l
À1
. Of the nine critical care units, only two had a median transfusion trigger below the nationally accepted guideline level of 70 g.l
. However, one of these units had a low number of transfusion episodes, Figure 1 Modified consort diagram: Transfusions recruited to the study in each centre are described, with reasons for exclusion coded in the key, total numbers included and numbers for the non-cardiac subgroup. Key: a: Actively bleeding; b: < 24 hours post major surgery; c: < 24 hours post major trauma; d: < 24 hours GI bleed; e: local protocol; f: pre major surgery. and it is difficult to know whether this represented better compliance with guidelines, reflected the patient cohort served by this particular unit, or was a chance observation. As Fig. 2 and Tables 2 and 3 show, some units within the Wessex region clearly follow national guidelines better than others by using a transfusion trigger of < 70 g.l
. Thirty-eight per cent of transfusions occurred outside of routine working hours (defined as between 08:00 and 20:00), ranging from 0% to 59% between units (Fig. 3) . The decision to transfuse, and the subsequent transfusion for this non-bleeding cohort should ideally have been when there were more intensive care staff present (i.e. during the day), due to the risks associated with blood transfusion and the semi-elective nature of the procedure.
For 23% of transfusions, more than one unit was given -in other words, at least two units were given 'back-to-back', without rechecking Hb levels between transfusions. This goes against national guidance, which supports the concept that one unit should be transfused at a time, with haemoglobin concentration being checked again after transfusion of each unit (outside the case of acute blood loss) [9] .
The reasons for this variability in compliance with national guidelines is not clear, but our findings echo results from previous studies [5, 6] . There is a national drive in the UK to decrease the usage of blood products from National Health Service Blood and Transplant (NHSBT) [13] . Overall, ICU teams in Wessex have relatively poor compliance with current evidence and guidelines, which indicate that a threshold of 70 g.l À1 is safe in stable critically ill patients. Consequently, a scarce and potentially harmful [14] therapy (blood) is being over-used within critical care in our region. It may be that clinicians remain sceptical of the evidence, and are concerned about the balance of harm and benefit for blood transfusion when faced with a patient with anaemia. Alternative explanations include: biased belief systems; non-acceptance of a non-inferiority design; or concerns about the quality of the evidence. There are few RCTs, and the majority of evidence comes from observational studies: "Randomized clinical trials in heterogeneous groups of critically ill patients to determine the benefit of a higher or lesser *Following either arterial blood gas or laboratory haemoglobin concentration measurement. †'Out of hours' defined as 20:00-08:00 h. ‡'Back-to-back' refers to occasions where a transfusion was commenced shortly after another had finished without any evidence of a repeat measurement of haemoglobin concentration. *Percentage of transfusions using a threshold of < 70 g.l
could be achieved by either arterial blood gas or laboratory haemoglobin concentration measurement.
transfusion trigger are likely to show equivalence as in each of the two arms of the study, some of the patients will benefit and others will not, or will even be harmed" [15] . The strengths of this regional audit are: its prospective design; consecutive patient recruitment; multicentre nature, and robust application of inclusion and exclusion criteria. We are confident that no transfusion episodes were included where a patient was actively bleeding, because all such patients were not studied following review by the data collectors. To validate this approach, all cases were additionally crossreferenced with the medical notes. When there was any doubt, the transfusion episode was removed. Furthermore, we also gave clinicians the benefit of the doubt and selected the lower of the two values (laboratory haemoglobin concentration vs. arterial blood gas value) as the presumed trigger, when it is entirely possible that this was not the case. This UK regional audit highlights the value and success of trainee networks in collecting valuable audit data that can shed light on clinically significant variations in regional practice.
The limitations of this audit are that certain centres had very few transfusion episodes. Anecdotally, we can report that one of these centres had a very strict protocol, with all senior medical staff working within that unit following national guidance meticulously.
Effective blood management is a 'win win' situation [16] , with benefits for both the patient and the healthcare system. In recognition of this, transfusion practices throughout NHS hospitals are gradually changing: increased cell salvage; less invasive surgery; fewer peri-operative blood transfusions; better management of pre-operative anaemia; early correction of coagulopathies; and increased use of intravenous iron, etc. This audit highlights the potential value of standardising protocols and guidelines within critical care networks, and the important information that can be gained by evaluating administered care against those guidelines. Quality improvement initiatives to improve compliance with guidelines appear justifiable.
Electronic healthcare records and clinical information systems used within intensive care units offer opportunities to include systems that measure and encourage compliance with best practice guidelines. These could highlight that elective blood prescription should only be prompted by a laboratory blood sample with a haemoglobin concentration < 70 g.l
, and promote single-unit transfusion. Clinician overrides could promote safety by ensuring that patients who are acutely bleeding are not denied blood transfusion. In conclusion, there is evidence and clear national guidance that a transfusion threshold of 70 g.l À1 is non-inferior (and possibly superior) to higher thresholds for non-cardiac, stable, critically ill patients who are not actively bleeding. Despite this, we have frequently deviated from this practice within our region, and we have every reason to suspect that this pattern of non-compliance may be similar across the country. Perhaps changes in culture and targeted use of clinical information systems will improve our future practice, and in so doing help us to benefit both patients and the healthcare system?
